The size of the Safety Syringes Market in North America has been calculated at USD 2.24 Billion in 2022. It is further predicted to grow and be worth USD 3.27 Billion by 2027, registering a CAGR of 7.81% between 2022 and 2027.
The North American safety syringes market is expected to be driven by the factors such as the increase in the number of needlestick injuries and the rising prevalence of bloodborne diseases. In addition, North American market growth is expected to be favored by factors such as an increase in the prevalence of chronic diseases such as diabetes and an increase in the incidence of needlestick injuries. The safety feature is intended to keep healthcare professionals safe from needlestick injuries.
Many governments and non-government organizations are attempting to reduce the number of needlestick injuries. As well as a government drives to include the use of safety syringes in legislation, favorable reimbursement policies, and improved syringe safety mechanisms due to a highly aware population, advanced healthcare infrastructure, promising government initiatives, the introduction of new safety syringes in most healthcare establishments, and significant companies in the region. Other factors include the availability of advanced healthcare infrastructure, growing awareness and the launch of advanced syringes, and major companies in North America.
Furthermore, diabetes affected In the North American safety syringes market, there has been an increase in healthcare spending, a rise in the occurrence of bloodborne infections, and a growth in awareness of the benefits of safety syringes. In addition, the growing geriatric population significantly contributes to the safety syringes market, as the senior population is vulnerable to various chronic diseases such as cancer, diabetes, and obesity; therefore, increasing the demand for the North American safety syringes market. In addition, several countries have enacted legislation requiring the use of safety syringes to reduce needlestick injuries and prevent needle re-use. As a result of these rules, safety syringes are anticipated to be used more frequently than regular syringes.
Alternative medication delivery systems and expensive costs, on the other hand, are limiting the market's expansion. Furthermore, the region's market expansion has been hampered by a lack of understanding of emerging economies' healthcare and safety risks.
This research report on the North American safety syringes market has been segmented and sub-segmented into the following categories:
By End Users:
Geographically North America is expected to grow at the highest CAGR throughout the forecast due to its high population base, development in healthcare infrastructure, and an increase in incidences of needlestick injuries. In addition, the favorable reimbursement policies, Furthermore, to enhance awareness, WHO and UNICEF are implementing several safe immunization campaigns throughout the region. Because the United States and Canada have significant market growth potential, several large U.S.-based corporations have expanded into the region. Many companies in the region are advanced safety syringes and new technological advancements. The United States approved the Needlestick Safety and Prevention Act, the first national law requiring the use of safety-engineered devices in healthcare settings to limit the risk of sharps injuries and blood exposures to healthcare workers.
The United States dominated the North American safety syringes market, and it is most likely to continue its dominance throughout the forecast period. The factors such as high healthcare spending, technological advancements healthcare sector, and supportive government policies are propelling market growth. In the United States, the Consolidated Appropriations Act allows the Department of Health and Human Services to use the funding to support syringe service programs, with the restriction that Needles and syringes are not allowed to be purchased with finances.
On the other hand, the Canadian Safety syringes market is projected to grow at a promising pace during the forecast period. The increasing incidence of needle stick injuries, the growing usage of safety syringes compared to conventional syringes, and government initiatives to incorporate safety syringes in the legislation boost market growth.
KEY MARKET PLAYERS:
Companies playing a dominant role in the North American safety syringes market profiled in this report are Covidien plc, Retractable Technologies Inc., Becton, Dickinson & Company, Terumo Corporation, Unilife Corporation, Revolutions Medical Corporation, Smiths Medical, Sol-Millennium, Ultimed Inc., and Axel Bio Corporation.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Technology
5.1.1 Retractable safety syringes
188.8.131.52 Automatic retractable safety syringes
184.108.40.206 Manual retractable safety syringes
5.1.2 Non-Retractable safety syringes
220.127.116.11 Sheathing tube syringes
18.104.22.168 Sliding needle cover syringes
22.214.171.124 Hinged needle cover syringes
5.2 By Therapy
5.2.2 Glucagon-like peptide-1 (glp-1)
5.2.4 Growth hormones
5.3 By End User
5.3.2 Home Care
6. Geographical Analysis
6.2 United States
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Becton, Dickinson & Company
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Covidien plc
8.3 Revolutions Medical Corporation
8.4 Retractable Technologies, Inc.
8.5 Smiths Medical
8.6 Unilife Corporation
8.7 Terumo Corporation
8.9 Ultimed, Inc.
8.10 Axel Bio Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.